» Articles » PMID: 35937239

Association Between Cancer Prevalence and Different Socioeconomic Strata in the US: The National Health and Nutrition Examination Survey, 1999-2018

Overview
Specialty Public Health
Date 2022 Aug 8
PMID 35937239
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inequality in health outcomes in relation to Americans' socioeconomic status (SES) is rising. American Cancer Society depicts that the most common cancers are diagnosed in men and women in 2021. We aim to study socioeconomic inequalities in related cancers to investigate whether the cancer prevalence differs within the family income to poverty ratio (PIR).

Methods: The study investigated data from adults aged 20-85 years participated in the 1999-2018 National Health and Nutrition Examination Survey (NHANES) who had complete data available on PIR and cancer or malignancy information ( = 49,720). Participants were stratified into 3 categories of PIR: high income (PIR ≥ 4), middle income (>1 and <4), or at or below the federal poverty level (≤1).

Results: The prevalence of prostate cancer was higher in the middle-income (3.61% [ = 464]) and high-income groups (3.36% [ = 227]) than in the low-income group (1.83% [ = 84], all < 0.001). The prevalence of breast cancer was higher in middle-income (2.86% [ = 390]) and high-income participants (3.48% [ = 218]) than in low-income participants (2.00% [ = 117], all < 0.001). Compared with the low-income group in men (0.48% [ = 22]), a higher prevalence of colon and rectum cancer occurs in the middle-income (0.87% [ = 112], = 0.012) and high-income groups (0.89% [ = 58], = 0.018). The prevalence of lung cancer in women was lower in high-income participants than middle-income participants (0.10% [ = 6] vs. 0.29% [ = 39], = 0.014).

Conclusions: Increasing disparities in cancer prevalence were identified across all socioeconomic categories analyzed in this study. To ensure the sustainable development goals, it is a global health priority to understand inequalities in health and to target interventions accordingly.

Citing Articles

A cross-sectional study on the association between physical activity and the risk of colon cancer based on NHANES 2007-2018.

Zou D, Xin X, Xu Y, Xu H, Xu T Sci Rep. 2025; 15(1):3297.

PMID: 39865142 PMC: 11770084. DOI: 10.1038/s41598-025-88067-4.


Association between family income to poverty ratio and severe headache/migraine in the American adults: data from NHANES 1999-2004.

Sun L, Zhao R, You X, Meng J, Meng L, Di H Front Neurol. 2024; 15:1427277.

PMID: 39624670 PMC: 11609074. DOI: 10.3389/fneur.2024.1427277.


Association between serum unsaturated fatty acids levels and infertility among American women from the National Health and Nutrition Examination Survey 2013-2014.

Wang L, Bai X, Zhao L, Li X, Mu F, Liu C Lipids Health Dis. 2024; 23(1):377.

PMID: 39543680 PMC: 11566495. DOI: 10.1186/s12944-024-02366-9.


Nonlinear associations between the ratio of family income to poverty and all-cause mortality among adults in NHANES study.

Yi H, Li M, Dong Y, Gan Z, He L, Li X Sci Rep. 2024; 14(1):12018.

PMID: 38797742 PMC: 11128441. DOI: 10.1038/s41598-024-63058-z.


Association of socioeconomic status and overactive bladder in US adults: a cross-sectional analysis of nationally representative data.

Lin W, Li T, Xu Z, Chen P, Zheng Q, Hong Y Front Public Health. 2024; 12:1345866.

PMID: 38596511 PMC: 11003547. DOI: 10.3389/fpubh.2024.1345866.


References
1.
Joseph D, King J, Dowling N, Thomas C, Richardson L . Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018. MMWR Morb Mortal Wkly Rep. 2020; 69(10):253-259. PMC: 7075255. DOI: 10.15585/mmwr.mm6910a1. View

2.
. The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Oncol. 2018; 19(10):1289-1306. PMC: 6167407. DOI: 10.1016/S1470-2045(18)30447-9. View

3.
Mackillop W, Zhang-Salomons J, Boyd C, Groome P . Associations between community income and cancer incidence in Canada and the United States. Cancer. 2000; 89(4):901-12. DOI: 10.1002/1097-0142(20000815)89:4<901::aid-cncr25>3.0.co;2-i. View

4.
Loeb S, Folkvaljon Y, Damber J, Alukal J, Lambe M, Stattin P . Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer. J Clin Oncol. 2017; 35(13):1430-1436. PMC: 5455459. DOI: 10.1200/JCO.2016.69.5304. View

5.
Cheng I, Witte J, McClure L, Shema S, Cockburn M, John E . Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control. 2009; 20(8):1431-40. PMC: 2746891. DOI: 10.1007/s10552-009-9369-0. View